CXCR4 and neoplasm: In addition, a 99mTc-labelled agent, [99mTc]TcAMD3465, has been explored for imaging CXCR4 expression in preclinical studies and has shown a significantly high tumour to background ratio; this will be useful in developing countries where PET imaging is not widely available.